Imager ii angiographic catheter 에 대한 현장 안전성 서한

Agency for Medical Products and Medical Devices of Croatia에 따르면, 해당 현장 안전성 서한 는 Croatia 에서 Boston Scientific Corporation, USA 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

현장 안전성 서한은 의료기기 제조사 또는 제조사 대리인이 시중에 유통되고 있는 자사 의료기기 제품에 대하여 취할 수 있는 조치를 알리는 소통방식입니다. 주요 대상층은 보건의료업계 종사자와 의료기기 사용자들입니다. 여기에는 회수(recall) 조치와 경고도 포함될 수 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Field Safety Notice
  • 사례 ID
    2012_volontary_withrawal_of_certain_batches_of_the_medical_device_imager_ii_angiographic_catheter_646
  • 날짜
    2012-04-26
  • 사례 국가
  • 사례 출처
    AMPMDC
  • 사례 출처 URL
  • 비고 / 경고
    Croatian data is current through September 2015. All of the data comes from the Agency for Medical Products and Medical Devices of Croatia, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Croatia.
  • 데이터 추가 비고
    Medical Intertrade d.o.o., the registration holder of this medical device in Croatia, has informed the Agency for Medicinal Products and Medical Devices (HALMED) about the volontary withrawal of certain batches of medical devices IMAGER II angiographic catheter, manufactured by Boston Scientific Corporation, USA, due to a detected quality defects in certain product batches.
    Boston Scientific Corporation, USA, the manufacturer , has received reclamations about defective packagings, resulted from physical interactions between the carton on the pouch where the hub is located which may cause contamination of the product. Therefore, the manufacturer has taken precautions measures and decided to withraw all the affected batches.
    IMAGER II angiographic catheters are sterile, single-use diagnostic intravascular catheters used exclusively in Health Care Facilities, are used to deliver a bolus of contrast to a patient when obtaining an image of a large area (aorta, leg-run off, etc.).
    Medical Intertrade d.o.o., the registration holder of this medical device in Croatia, has recalled all nine batches found on the Croatian market affected by afore mentioned defect.
    None of the adverse events referred to the described packaging defect of IMAGER II angiographic catheter has been reported by now in the Republic of Croatia.
    The manufacturer has run an investigation and has found out the cause for packaging defects and has initiated corrective measures in order to prevent the reappearence of those defects.

Device

Manufacturer

  • 제조사 모회사 (2017)
  • 제조사 의견
    “We take a patient-first approach to assessing the applicability of every recall and communicate to regulatory bodies in all geographies where the recalled device is sold,” Boston Scientific said in a statement to ICIJ. “We have coordinated several recalls across many countries in a timely manner,” the company said, adding that it complies with all national laws, which can often vary and require different processes for reporting information or taking action on recalls. The company said it uses a rigorous and uniform process to take action on recalls and that “when we initiate a field action (e.g. recall, safety alert), every customer who has received an affected product receives a communication that includes a letter for the physician.”
  • Source
    AMPMDC